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ABSTRACT  
Aims & Objectives: To evaluate or screen the anticonvulsant effect of Nicorandil a potassium channel opener in Pentylenetetrazole (PTZ) 
induced convusions in albino mice. Materials & Methods: Mice of either sex weighing 20-25gms were selected for the present study. 
The animals were divided into 6 groups with each group consisting of 6 albino mice. Group 1 mice received placebo (0.2ml of distilled 
water) intraperitoneally (i.p), group 2 received sodium valproate 200 mg/kg/i.p. as positive control, while groups 3,4, 5 and 6 were 
administered Nicorandil 5, 10, 20 and 40 mg/kg i.p respectively. Pentylenetetrazole (PTZ) was administered in the dose of 100mg/kg i.p, 
30mins after Nicorandil/ control drug pre-treatment. Onset and duration of clonic convulsion were recorded. Results: Nicorandil 
pretreatment in the dose of 5mg/kg increased onset time and significantly decreased the duration of convulsions, while the doses of 10, 
20, 40mg/kg prevented the convulsions. Conclusion: Nicorandil possesses significant anticonvulsant activity comparable to sodium 
valproate on PTZ induced seizure in albino mice. 
KEYWORDS: Pentylenetetrazole, Sodium valproate, Nicorandil, Anticonvulsant activity. 
INTRODUCTION 
Epilepsy is a common chronic neurological condition that is 
characterized by recurrent unprovoked epileptic seizure. It 
affects approximately 50 million people worldwide [1]. 
Recurrent seizures, interferes with a patient’s ability to carry out 
day-to-day activities. Pharmacological therapy remains the 
cornerstone of epilepsy treatment [1].  
The potassium channel openers like Nicorandil, cromakalim, 
pinacidil, diazoxide and minoxidil are a group of drugs which 
produce stabilizing action on cell membranes through 
membrane hyper polarization via increased transmembrane K+ 
conductance [2]. They have been found to exert various neuro and 
psychopharmacological effects and modulate neurotransmitter 
release. Vanden Bussche and associates first suggested that they 
might inhibit seizure spread in epilepsy by blockade of neuronal 
Ca2+channels [3].  Later other workers showed that the K+ channel 
openers prevent or ameliorate seizure induced by mast cell 
degranulating peptide (MCDP) [4,5]. However, they have no 
effect in seizure induced by other K+ channel blockers. 
These observations have led to an inquisitive interest in K+ 
Channel openers as a possible anti-convulsing agent. The 
present study was thus planned to evaluate the anti-convulsant 
effect of a K+ channel opener Nicorandil, on PTZ induced 
convulsions in albino mice. 
MATERIALS AND METHODS 
The mice of either sex weighing 20-25gm were selected, one 
week prior to study. The animals were maintained in accordance 
with the Committee for the purpose of control and supervision 
on experimental animals (CPCSEA) guidelines, temperature of 
(23±2)0C, humidity 50±5%, 12hr light: dark cycles. Animals 
were housed in polypropylene cages (UN Shah Manufactures, 
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Mumbai, India), provided with standard food (Hindustan lever 
ltd, Mumbai, India) and water ad libitium. Institutional animal 
ethics committee permission was obtained prior to study. 
The animals were divided into 6 groups (n=6). Group 1 received 
0.2ml of distilled water i.p, served as negative control. Group 2 
received sodium valproate 200 mg/kg/i.p. served as positive 
control. Groups 3, 4, 5 and 6 were administered Nicorandil 5, 
10, 20 and 40 mg/kg/i.p respectively. PTZ was administered at 
the dose of 100mg/kg/i.p, 30 minutes after Nicorandil/ control 
drug pre-treatment in all groups [6,7]. Onset and duration of clonic 
convulsion were recorded in all the mice.  
STATISTICAL ANALYSIS 
Results were analyzed by one-way analysis of variance 
(ANOVA).The level of statistical significance was set at p<0.05. 
RESULTS 
The onset of convulsions and duration of convulsions in mice 
the on PTZ induced convulsions were 5.50min and 12.50min in 
the negative control group. (sodium Valproate 200mg/kg), 
Nicorandil 10 mg/kg, Nicorandil20 mg/kg and Nicorandil 40 
mg/kg demonstrated 100 % protection from PTZ induced 
seizures, clonic convulsions were not observed in any mice in 
these  groups. Nicorandil pretreatment in the dose of 5mg/kg 
increased onset time and significantly decreased the duration of 
convulsions 4.67min and 6.33min respectively. 
 
Figure 1. PTZ-induced convulsions (onset of action) 
The onset of PTZ induced convulsions were reduced with 5mg 
dose of Nicorandil which was not significant statistically but 
there was no convulsions (100% protection) with Sodium 
Valproate, Nicorandil 10mg, 20mg and 40mg. (Figure 1). 
 
Figure 2. PTZ-induced convulsions (duration of action) 
The duration of PTZ induced convulsions reduced with 5mg 
dose of Nicorandil (p<0.001) and there was no convulsion 
(100% protection) with Sodium Valproate, Nicorandil 10mg, 
20mg and 40mg. (Figure 2). 
DISCUSSION 
Clonic convulsions produced by PTZ in mice were prevented by 
drugs effective in absence seizures. Activity in this model 
represents action on seizure focus itself.[8,9]  Pentylenetetrazol, 
also known as Metrazol, Leptazol, Cardiazol, and Corazol was 
used as a central nervous system stimulant. Soaje-Echaque and 
Lim used adult albino mice to study the anticonvulsant effects 
[10]. In their study animals were initially administered with an 
anti convulsant, later they were injected with PTZ 
100mg/kg/i.p., 112mg/kg/s.c through tail vein. The volume of 
solution, not exceeding 0.25 ml, is injected in 4 seconds or less, 
using a 0.25-ml syringe and a 27-gauge needle. Animals were 
observed for the effect of anticonvulsant. In the current study 
also the same procedure was followed, to identify the 
antiepileptic activity of Nicorandil on PTZ model.  
One potential anti-epileptic that has not been adequately 
exploited is K+ channel opening. K+ channels play a major role 
in the control of all aspects of neuronal excitability, including 
resting membrane potential, responsiveness to synaptic inputs, 
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spike frequency adaptation and neurotransmitter release. To 
date, 80 or more K+ channel related genes have been identified 
in the human genome, and genetic, molecular, physiological and 
pharmacological evidence now exists to support a role for some 
of these K+ channels in the control of neuronal excitability and 
epileptogenesis.[11] 
CONCLUSION 
Administration of Nicorandil 30 minutes prior to PTZ abolished 
the convulsions completely. Hence, Nicorandil possesses 
significant anticonvulsant activity against absence seizures in 
albino mice. The antiepileptic activity of Nicorandil is 
comparable to sodium valproate in the PTZ model. Further 
studies are required for establishing antiepileptic property of 
Nicorandil and confirming its mechanism action using other 
models of convulsion. 
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